https://microcapopportunities.substack.com/archivedailyhttps://microcapopportunities.substack.com/aboutweeklyhttps://microcapopportunities.substack.com/podcastweeklyhttps://microcapopportunities.substack.com/p/biosyent-a-financial-outlier-in-the2026-06-08monthlyhttps://microcapopportunities.substack.com/p/2026-ytd-mco-portfolio-annualized2026-06-05monthlyhttps://microcapopportunities.substack.com/p/multibaggers-turnarounds-and-steady-d262026-05-31monthlyhttps://microcapopportunities.substack.com/p/perimeter-medical-imaging-mco-thesis2026-05-29monthlyhttps://microcapopportunities.substack.com/p/thermal-energy-international2026-05-27monthlyhttps://microcapopportunities.substack.com/p/new-horizon-aircraft-second-raise2026-05-27monthlyhttps://microcapopportunities.substack.com/p/enwave-a-royalty-machine-stuck-in2026-05-26monthlyhttps://microcapopportunities.substack.com/p/paragon-advanced-labs-thesis-check2026-05-25monthlyhttps://microcapopportunities.substack.com/p/ieh-corporation-undergoing-resurgence2026-05-24monthlyhttps://microcapopportunities.substack.com/p/mco-thesis-in-play-new-horizon-aircraft2026-05-22monthlyhttps://microcapopportunities.substack.com/p/tat-tech-bottleneck-now-has-two-fronts2026-05-22monthlyhttps://microcapopportunities.substack.com/p/neuraxis-va-ramp2026-05-21monthlyhttps://microcapopportunities.substack.com/p/branchout-food-is-building-a-snack2026-05-21monthlyhttps://microcapopportunities.substack.com/p/electrovaya-energy-storage-pivot2026-05-19monthlyhttps://microcapopportunities.substack.com/p/widepoint-57-pt-and-platform-thesis2026-05-18monthlyhttps://microcapopportunities.substack.com/p/neuroone-medical-technologies-has2026-05-17monthlyhttps://microcapopportunities.substack.com/p/neuraxis-q1-2026-the-kpis-tell-the2026-05-13monthlyhttps://microcapopportunities.substack.com/p/hovr-why-putting-20m-in-the-bank2026-05-12monthlyhttps://microcapopportunities.substack.com/p/mco-sanuwave-health-check2026-05-12monthlyhttps://microcapopportunities.substack.com/p/paragon-advanced-labs-has-multibagger2026-05-11monthlyhttps://microcapopportunities.substack.com/p/cematrix-bookings-tell-a-different2026-05-07monthlyhttps://microcapopportunities.substack.com/p/cybeats-technologies-cybtcn-a-sbom2026-05-05monthlyhttps://microcapopportunities.substack.com/p/our-meet-list-for-the-2026-planet2026-05-04monthlyhttps://microcapopportunities.substack.com/p/mco-portfolio-stats-update-2026-off2026-05-01monthlyhttps://microcapopportunities.substack.com/p/multibaggers-turnarounds-and-steady-07a2026-04-30monthlyhttps://microcapopportunities.substack.com/p/aurora-spine-exiting-position2026-04-30monthlyhttps://microcapopportunities.substack.com/p/perimeter-medical-imaging-pynkf-setting2026-04-29monthlyhttps://microcapopportunities.substack.com/p/why-widepoint-becomes-the-platform2026-04-28monthlyhttps://microcapopportunities.substack.com/p/neuraxis-building-a-commercial-powerhouse2026-04-26monthlyhttps://microcapopportunities.substack.com/p/perimeter-medical-imaging-ai-financing2026-04-21monthlyhttps://microcapopportunities.substack.com/p/new-horizon-cavorite-x7-crosses-from2026-04-25monthlyhttps://microcapopportunities.substack.com/p/perimeter-medical-imagine-ai-showtime2026-04-20monthlyhttps://microcapopportunities.substack.com/p/aurora-spine-signal-points-to-a-record2026-04-19monthlyhttps://microcapopportunities.substack.com/p/perimeter-medical-imaging-ai-update2026-04-17monthlyhttps://microcapopportunities.substack.com/p/electrovaya-elva-defense-orders-the2026-04-10monthlyhttps://microcapopportunities.substack.com/p/perimeter-medical-imaging-ai-a-data2026-04-08monthlyhttps://microcapopportunities.substack.com/p/multibaggers-turnarounds-and-steady-4042026-04-01monthlyhttps://microcapopportunities.substack.com/p/adding-perimeter-medical-imaging2026-03-30monthlyhttps://microcapopportunities.substack.com/p/neuraxis-what-a-cpt-category-i-code2026-04-01monthlyhttps://microcapopportunities.substack.com/p/widepoint-q4-2025-earnings-recap2026-03-29monthlyhttps://microcapopportunities.substack.com/p/neuraxis-upgrade-behind-the-scenes2026-03-26monthlyhttps://microcapopportunities.substack.com/p/video-interview-horizon-aircraft-d432026-03-23monthlyhttps://microcapopportunities.substack.com/p/tat-technologies-we-anticipated-the2026-03-25monthlyhttps://microcapopportunities.substack.com/p/neuraxis-last-call-before-full-commercialization2026-03-21monthlyhttps://microcapopportunities.substack.com/p/electrovaya-stage-set-for-successful2026-06-10monthlyhttps://microcapopportunities.substack.com/p/electrovaya-a-turnaround-play2026-06-09monthlyhttps://microcapopportunities.substack.com/p/tat-technologies-locks-in-opportunity2026-06-08monthlyhttps://microcapopportunities.substack.com/p/ascent-industries-turnaround-is-complete2026-03-08monthlyhttps://microcapopportunities.substack.com/p/cematrix-a-mispriced-stock-experiencing2026-03-08monthlyhttps://microcapopportunities.substack.com/p/neuraxis-microcapclub-video2026-05-26monthlyhttps://microcapopportunities.substack.com/p/our-flagship-stock-neuraxis-nrxs2026-03-01monthlyhttps://microcapopportunities.substack.com/p/multibaggers-turnarounds-and-steady-f522026-05-24monthlyhttps://microcapopportunities.substack.com/p/join-my-new-subscriber-chat2026-02-27monthlyhttps://microcapopportunities.substack.com/p/cematrix-deserves-a-fresh-look2026-05-18monthlyhttps://microcapopportunities.substack.com/p/video-interview-aurora-spine-asgv2026-02-18monthlyhttps://microcapopportunities.substack.com/p/diagnos-fooled-us2026-05-10monthlyhttps://microcapopportunities.substack.com/p/multibaggers-turnarounds-and-steady-6412026-05-04monthlyhttps://microcapopportunities.substack.com/p/neuraxis-technical-alert2026-04-27monthlyhttps://microcapopportunities.substack.com/p/widepoint-is-lined-up-to-increase2026-04-22monthlyhttps://microcapopportunities.substack.com/p/neuraxis-enters-veterans-market2026-04-16monthlyhttps://microcapopportunities.substack.com/p/derm-journey-medical-closing-position2026-04-06monthlyhttps://microcapopportunities.substack.com/p/2025-mco-portfolio-correction2026-03-31monthlyhttps://microcapopportunities.substack.com/p/2025-year-end-results-for-mco-portfolio2026-04-08monthlyhttps://microcapopportunities.substack.com/p/neuraxis-escalates-commercial-rollout2026-03-30monthlyhttps://microcapopportunities.substack.com/p/neuraxis-its-big2026-03-23monthlyhttps://microcapopportunities.substack.com/p/neuraxis-update-anthem-coverage-guidelines2026-03-21monthlyhttps://microcapopportunities.substack.com/p/revenue-down-momentum-up-parsing2026-04-20monthlyhttps://microcapopportunities.substack.com/p/video-interview-diagnos-adkv-with2025-12-21monthlyhttps://microcapopportunities.substack.com/p/titanic-news-for-neuraxis-adding2026-03-14monthlyhttps://microcapopportunities.substack.com/p/multibaggers-turnarounds-and-steady-b892026-03-09monthlyhttps://microcapopportunities.substack.com/p/multibaggers-turnarounds-and-steady2026-02-23monthlyhttps://microcapopportunities.substack.com/p/widepoint-is-still-a-cheap-stock2026-02-16monthlyhttps://microcapopportunities.substack.com/p/portfolio-change-4652025-11-20monthlyhttps://microcapopportunities.substack.com/p/neuraxis-negative-information-hot2026-02-09monthlyhttps://microcapopportunities.substack.com/p/multibaggers-turnarounds-steady-eddies2026-02-01monthlyhttps://microcapopportunities.substack.com/p/introducing-diagnos-inc2026-01-26monthlyhttps://microcapopportunities.substack.com/p/neuraxis-gaining-total-addressable2026-01-20monthlyhttps://microcapopportunities.substack.com/p/neuraxis-fda-filing-stokes-upward2026-01-13monthlyhttps://microcapopportunities.substack.com/p/neuraxis-projecting-2026-revenue-a0f2026-01-11monthlyhttps://microcapopportunities.substack.com/p/neuraxis-projecting-2026-revenue2026-01-09monthlyhttps://microcapopportunities.substack.com/p/kneat-continues-to-scale2026-01-05monthlyhttps://microcapopportunities.substack.com/p/mco-portfolio-has-spectacular-september2025-12-30monthlyhttps://microcapopportunities.substack.com/p/catalysts-technical-analyses-artificial2025-12-28monthlyhttps://microcapopportunities.substack.com/p/does-hydra-aero-take-aurora-spine2025-10-02monthlyhttps://microcapopportunities.substack.com/p/tat-technologies-long-term-strategy2025-12-22monthlyhttps://microcapopportunities.substack.com/p/neuraxis-proceeding-according-to2025-12-21monthlyhttps://microcapopportunities.substack.com/p/shining-a-light-on-what-is-new-and2025-12-15monthlyhttps://microcapopportunities.substack.com/p/mco-neuraxis-articles2025-12-13monthlyhttps://microcapopportunities.substack.com/p/we-like-journey-medical-and-neuraxis2025-12-08monthlyhttps://microcapopportunities.substack.com/p/coya-therapeutics-rating-change2025-09-07monthlyhttps://microcapopportunities.substack.com/p/august-results-are-in-for-mco-portfolio2025-11-28monthlyhttps://microcapopportunities.substack.com/p/neuraxis-share-structure-understanding2025-09-03monthlyhttps://microcapopportunities.substack.com/p/neuraxis-is-at-the-best-hospitals2025-11-24monthlyhttps://microcapopportunities.substack.com/p/busy-month-at-mco2025-11-21monthlyhttps://microcapopportunities.substack.com/p/portfolio-alert-9792025-08-28monthlyhttps://microcapopportunities.substack.com/p/horizon-aircraft-targeting-an-opportunity2025-11-17monthlyhttps://microcapopportunities.substack.com/p/video-interview-horizon-aircraft2025-09-01monthlyhttps://microcapopportunities.substack.com/p/neuraxis-treating-virtually-no-one2025-11-10monthlyhttps://microcapopportunities.substack.com/p/portfolio-change-1052025-08-13monthlyhttps://microcapopportunities.substack.com/p/neuraxis-is-looking-like-a-slam-dunk2025-08-13monthlyhttps://microcapopportunities.substack.com/p/portfolio-change-7f52025-08-13monthlyhttps://microcapopportunities.substack.com/p/ascent-forecast-to-a-new-price-high2025-08-10monthlyhttps://microcapopportunities.substack.com/p/portfolio-changes2025-08-08monthlyhttps://microcapopportunities.substack.com/p/connect-biopharma-is-exploiting-a2025-10-29monthlyhttps://microcapopportunities.substack.com/p/july-performance-drives-portfolio2025-10-27monthlyhttps://microcapopportunities.substack.com/p/mco-portfolio-update-for-end-of-july2025-10-23monthlyhttps://microcapopportunities.substack.com/p/removing-frequency-electronics-feim2025-07-30monthlyhttps://microcapopportunities.substack.com/p/adding-journey-medical-derm-to-the2025-07-28monthlyhttps://microcapopportunities.substack.com/p/vtwo-is-up-and-me-too2025-10-20monthlyhttps://microcapopportunities.substack.com/p/portfolio-heats-up-to-42-annual-return2025-10-03monthlyhttps://microcapopportunities.substack.com/p/why-an-insider-just-made-a-huge-purchase2025-09-29monthlyhttps://microcapopportunities.substack.com/p/we-want-to-be-in-before-the-bean2025-09-22monthlyhttps://microcapopportunities.substack.com/p/neuraxis-nrxs-a-steal-at-current2025-09-16monthlyhttps://microcapopportunities.substack.com/p/taking-profits-on-gossamer-bio2025-06-22monthlyhttps://microcapopportunities.substack.com/p/testing-support-and-gapology-are2025-09-14monthlyhttps://microcapopportunities.substack.com/p/neuraxis-a-vast-unrecognized-market2025-09-07monthlyhttps://microcapopportunities.substack.com/p/the-steady-ascent-of-aurora-spine2025-06-09monthlyhttps://microcapopportunities.substack.com/p/technical-analysis-should-not-be2025-09-01monthlyhttps://microcapopportunities.substack.com/p/how-we-are-doing-on-our-aim-for-302025-08-27monthlyhttps://microcapopportunities.substack.com/p/microcap-opportunities-end-of-the2025-08-25monthlyhttps://microcapopportunities.substack.com/p/neuraxis-investment-case2026-06-03monthlyhttps://microcapopportunities.substack.com/p/microcap-opportunities-april-20252025-07-31monthlyhttps://microcapopportunities.substack.com/p/axil-brands-adds2025-07-28monthlyhttps://microcapopportunities.substack.com/p/end-of-april-2025-portfolio-review2025-07-24monthlyhttps://microcapopportunities.substack.com/p/ascent-industries-value-propulsion2025-07-20monthlyhttps://microcapopportunities.substack.com/p/portfolio-change-cd32025-07-10monthlyhttps://microcapopportunities.substack.com/p/portfolio-change2025-07-10monthlyhttps://microcapopportunities.substack.com/p/cntb-closing-position-after-run-up2025-07-09monthlyhttps://microcapopportunities.substack.com/p/widepoint-aligns-with-doge-objective2025-07-08monthlyhttps://microcapopportunities.substack.com/p/we-are-buying2025-06-30monthlyhttps://microcapopportunities.substack.com/p/end-of-march-2025-portfolio-review2025-06-20monthlyhttps://microcapopportunities.substack.com/p/aurora-spines-aero-fda-approval-is2025-06-18monthlyhttps://microcapopportunities.substack.com/p/nexalin-technology-is-ramping-up2025-06-11monthlyhttps://microcapopportunities.substack.com/p/vsee-health-a-next-gen-digital-healthcare2025-05-29monthlyhttps://microcapopportunities.substack.com/p/end-of-february-2025-portfolio-review2025-05-22monthlyhttps://microcapopportunities.substack.com/p/watchlist-32025-05-22monthlyhttps://microcapopportunities.substack.com/p/cardiol-therapeutics-bargain-stock2025-05-12monthlyhttps://microcapopportunities.substack.com/p/coya-therapeutics-halts-progression2025-05-03monthlyhttps://microcapopportunities.substack.com/p/microcap-opportunities-january-portfolio2025-05-01monthlyhttps://microcapopportunities.substack.com/p/end-of-january-2025-portfolio-review2025-04-24monthlyhttps://microcapopportunities.substack.com/p/neuraxis-has-crafted-an-inflection2025-04-17monthlyhttps://microcapopportunities.substack.com/p/frequency-electronics-and-quantum2025-04-14monthlyhttps://microcapopportunities.substack.com/p/watchlist-22025-04-13monthlyhttps://microcapopportunities.substack.com/p/clarification-alert-on-portfolio2025-04-09monthlyhttps://microcapopportunities.substack.com/p/portfolio-alert-wyy2025-04-08monthlyhttps://microcapopportunities.substack.com/p/vsee-building-of-a-next-generation2025-04-08monthlyhttps://microcapopportunities.substack.com/p/portfolio-alert2025-04-08monthlyhttps://microcapopportunities.substack.com/p/delcath-has-a-path-to-profitability2025-04-07monthlyhttps://microcapopportunities.substack.com/p/tat-technologies-catching-aviation2025-04-04monthlyhttps://microcapopportunities.substack.com/p/additions-to-mco-folio2025-04-03monthlyhttps://microcapopportunities.substack.com/p/our-watchlist2025-04-15monthlyhttps://microcapopportunities.substack.com/p/microcap-opportunities-2024-year-6cc2025-03-28monthlyhttps://microcapopportunities.substack.com/p/show-me-the-money-time-for-beamr2025-03-24monthlyhttps://microcapopportunities.substack.com/p/microcap-opportunities-2024-year2025-03-24monthlyhttps://microcapopportunities.substack.com/p/addition-and-whats-news-in-mco-portfolio2025-03-05monthlyhttps://microcapopportunities.substack.com/p/microcap-opportunities-portfolio-5a12025-02-25monthlyhttps://microcapopportunities.substack.com/p/microcap-opportunities-portfolio2025-02-18monthlyhttps://microcapopportunities.substack.com/p/aurora-spine-reports-record-q3-recap2025-02-12monthlyhttps://microcapopportunities.substack.com/p/widepoint-is-an-attractive-growth2025-02-09monthlyhttps://microcapopportunities.substack.com/p/mco-portfolio-november-2024-update2025-06-13monthlyhttps://microcapopportunities.substack.com/p/monthly-portfolio-update2025-06-13monthlyhttps://microcapopportunities.substack.com/p/how-to-handle-a-no-news-run-up2025-06-13monthlyhttps://microcapopportunities.substack.com/p/aurora-spine-why-the-60-additional2025-06-13monthlyhttps://microcapopportunities.substack.com/p/coya-therapeutics-has-several-near2025-06-13monthlyhttps://microcapopportunities.substack.com/p/updates2025-06-13monthlyhttps://microcapopportunities.substack.com/p/aurora-spine-large-chunk-of-warrants2024-12-11monthlyhttps://microcapopportunities.substack.com/p/aurora-spine-nothing-nothing-nothing2025-06-13monthlyhttps://microcapopportunities.substack.com/p/gossamer-bio-has-one-more-shot-on2025-06-13monthlyhttps://microcapopportunities.substack.com/p/microcap-opportunities-completes2025-06-13monthlyhttps://microcapopportunities.substack.com/p/cardiol-therapeutics-first-mover2025-06-13monthlyhttps://microcapopportunities.substack.com/p/cspi-a-spinoff-is-hopefully-developing2025-06-13monthlyhttps://microcapopportunities.substack.com/p/neuraxis-on-a-path-to-profitability2024-12-17monthlyhttps://microcapopportunities.substack.com/p/beam-global-update2025-06-13monthlyhttps://microcapopportunities.substack.com/p/kraken-robotics-update2025-06-13monthlyhttps://microcapopportunities.substack.com/p/intellinetics-update2025-06-13monthlyhttps://microcapopportunities.substack.com/p/bionomics-update2025-06-13monthlyhttps://microcapopportunities.substack.com/p/unusual-machines-update2025-06-13monthlyhttps://microcapopportunities.substack.com/p/frequency-electronics-thriving-in2025-06-13monthlyhttps://microcapopportunities.substack.com/p/kneat-dominates-life-science-validation2024-12-13monthlyhttps://microcapopportunities.substack.com/p/beem-global-push-to-profitability2025-06-13monthlyhttps://microcapopportunities.substack.com/p/kraken-robotics-pure-play-in-unmanned2024-11-26monthlyhttps://microcapopportunities.substack.com/p/intellinetics-is-expanding-market2025-06-13monthlyhttps://microcapopportunities.substack.com/p/bionomics-lead-drug-is-a-potential2025-06-13monthlyhttps://microcapopportunities.substack.com/p/unusual-machines-a-play-on-the-shift2025-06-13monthlyhttps://microcapopportunities.substack.com/p/aurora-spine-offers-low-risk-with2025-06-13monthly